Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell, CD-30+/ALK lymphoma. Late (9 years) periprosthetic fluid (seroma) is the most common presentation (90% of the cases). A combination of textured breast implant, bacterial contamination, and genetic predisposition seems to be necessary for BIA-ALCL to occur. There are 35 million patients with implants in the world, and at the present moment, 573 cases of BIA-ALCL have been reported. The risk of developing BIA-ALCL in Australia varies from 1:2832 to 1:86,029, with texture grades 3 and 4 seeming to pose a higher risk than grades 2 and 1. NCCN has established guidelines for diagnosis and treatment, and early diagnosis is the key to cure. At an early stage and for the vast majority of patients, the treatment consists of capsulectomy and implant removal. However, at stages II to IV, a systemic treatment is warranted, including chemotherapy, radiotherapy (residual disease), and brentuximab vedotin. The majority of patients can be cured, and complete capsular removal is the most important factor. So far, 33 patients have died from BIA-ALCL worldwide, with deaths related to delay in diagnosis and treatment. Textured implants have been in the midst of the current implant crisis, and Biocell was recalled worldwide after the latest FDA update on the disease. At the present moment, no medical society or regulatory agency has recommended implant removal. It is about time that we start robust breast implant registries to determine risks. Besides, based on scientific criteria, we must consider all the benefits and risks associated with the available breast devices.
Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Breast implants Silicone elastomers Lymphoma, large cell, anaplastic: breast
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
Conflict of interest
Dr. Groth has received a speaker honorarium from Allergan. The authors received no financial support for the research, authorship, and publication of this article.
Human and Animal Rights
This article did not require any studies with human participants or animals performed by any of the authors.
Informed consent is not required for this type of study.
Clemens MW, Horwitz SM (2017) NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J 37:285–289PubMedCrossRefGoogle Scholar
Aladily TN, Nathwani BN, Miranda RN et al (2012) Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas. Am J Surg Pathol 36:1729–1734PubMedCrossRefGoogle Scholar
Keech JA Jr, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100:554–555PubMedCrossRefGoogle Scholar
Rastogi P, Deva AK, Prince HM (2018) Breast implant-associated anaplastic large cell lymphoma. Curr Hematol Malig Rep 13:516–524PubMedCrossRefGoogle Scholar
Calobrace MB, Capizzi PJ (2014) The biology and evolution of cohesive gel and shaped implants. Plast Reconstr Surg 134:6S–11SPubMedCrossRefGoogle Scholar
Calobrace MB, Schwartz MR, Zeidler KR et al (2017) Long-term safety of textured and smooth breast implants. Aesthet Surg J 38:38–48PubMedCrossRefGoogle Scholar
Randquist C, Gribbe O (2010) Highly cohesive textured form stable gel implants: principles and techniques. In: Hall-Findlay EEG (ed) Aesthetic and reconstructive surgery of the breast. Elsevier, Philadelphia, pp 339–365CrossRefGoogle Scholar
Adams WP Jr, Culbertson EJ, Deva AK et al (2017) Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg 140:427–431PubMedCrossRefGoogle Scholar
McGuire P, Reisman NR, Murphy DK (2017) Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg 139:1–9PubMedCrossRefGoogle Scholar
Hall-Findlay EJ (2011) Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg 127:56–66PubMedCrossRefGoogle Scholar
Zingaretti N, Galvano F, Vittorini P et al (2019) Smooth prosthesis: our experience and current state of art in the use of smooth sub-muscular silicone gel breast implants. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-019-01464-9
Namnoum JD, Largent J, Kaplan HM et al (2013) Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type. J Plast Reconstr Aesthet Surg 66:1165–1172PubMedCrossRefGoogle Scholar
Jones P, Mempin M, Hu H et al (2018) The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg 142:837–849PubMedCrossRefGoogle Scholar
Collett DJ, Rakhorst H, Lennox P et al (2019) Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 143:30S–40SPubMedCrossRefGoogle Scholar
Hu H, Jacombs A, Vickery K et al (2015) Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 135:319–329PubMedCrossRefGoogle Scholar
Hu H, Johani K, Almatroudi A et al (2016) Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg 137:1659–1669PubMedCrossRefGoogle Scholar
Deva AK, Adams WP Jr, Vickery K (2013) The role of bacterial biofilms in device-associated infection. Plast Reconstr Surg 132:1319–1328PubMedCrossRefGoogle Scholar
Loch-Wilkinson A, Beath KJ, Knight RJW et al (2017) Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140:645–654PubMedCrossRefGoogle Scholar
Adams WP Jr, Conner WC, Barton FE Jr et al (2000) Optimizing breast pocket irrigation: an in vitro study and clinical implications. Plast Reconstr Surg 105:334–338 discussion 339-343PubMedCrossRefPubMedCentralGoogle Scholar
Blombery P, Thompson E, Ryland GL et al (2018) Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma. Oncotarget 9:36126–36136PubMedPubMedCentralCrossRefGoogle Scholar
Adams WP Jr (2017) Discussion: breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 140:663–665PubMedCrossRefGoogle Scholar
Brody GS, Deapen D, Taylor CR et al (2015) Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 135:695–705PubMedCrossRefGoogle Scholar
Doren EL, Miranda RN, Selber JC et al (2017) U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 139:1042–1050PubMedCrossRefGoogle Scholar
Magnusson M, Beath K, Cooter R et al (2019) The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg 143:1285–1292PubMedCrossRefGoogle Scholar
Ruffenach L, Bruant-Rodier C, Goldammer F et al (2019) Thirty-six (36) French cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn? Ann Chir Plast Esthet 64:285–292PubMedCrossRefGoogle Scholar
Clemens MW, Brody GS, Mahabir RC et al (2018) How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 141:586e–599ePubMedCrossRefGoogle Scholar
Di Napoli A, Pepe G, Giarnieri E et al (2017) Cytological diagnostic features of late breast implant seromas: from reactive to anaplastic large cell lymphoma. PLoS ONE 12:e0181097PubMedPubMedCentralCrossRefGoogle Scholar
Elswick SM, Nguyen MT (2018) Breast erythema in a patient with breast implant-associated anaplastic large cell lymphoma: a Case Report Discussing Cutaneous Manifestations. Aesthet Surg J 38:NP47–NP52PubMedCrossRefPubMedCentralGoogle Scholar
Deva AK (2018) Commentary on: Breast erythema in a patient with breast implant-associated anaplastic large cell lymphoma: a case report discussing cutaneous manifestations. Aesthet Surg J 38:NP53–NP55PubMedCrossRefPubMedCentralGoogle Scholar
Clemens MW, Jacobsen ED, Horwitz SM (2019) 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 39:S3–S13PubMedCrossRefPubMedCentralGoogle Scholar
Ramos-Gallardo G, Cuenca-Pardo J, Cardenas-Camarena L et al (2018) Is Latin America ready to identify anaplastic large cell lymphoma in breast implants patients? Regional encounter during the national plastic surgery meeting in Cancun, Mexico. Aesthetic Plast Surg 42:1421–1428PubMedCrossRefPubMedCentralGoogle Scholar
Santanelli di Pompeo F, Laporta R, Sorotos M et al (2015) Breast implant-associated anaplastic large cell lymphoma: proposal for a monitoring protocol. Plast Reconstr Surg 136:144e–151ePubMedCrossRefGoogle Scholar
Pro B, Advani R, Brice P et al (2012) Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol 30:2190–2196PubMedCrossRefGoogle Scholar
Clemens MW, Medeiros LJ, Butler CE et al (2016) Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol 34:160–168PubMedCrossRefGoogle Scholar
Clemens MW, Miranda RN, Butler CE (2016) Breast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg 137:1117–1122PubMedCrossRefGoogle Scholar
Giordano S, Peltoniemi H, Lilius P et al (2013) Povidone–iodine combined with antibiotic topical irrigation to reduce capsular contracture in cosmetic breast augmentation: a comparative study. Aesthet Surg J 33:675–680PubMedCrossRefGoogle Scholar
Swanson E (2017) Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): why the search for an infectious etiology may be irrelevant. Aesthet Surg J 37:NP118–NP121PubMedCrossRefGoogle Scholar
Campanale A, Boldrini R, Marletta M (2018) 22 cases of breast implant-associated ALCL: awareness and outcome tracking from the Italian Ministry of Health. Plast Reconstr Surg 141:11e–19ePubMedCrossRefGoogle Scholar
Teixeira BN (2018) Anaplasic large cells lymphoma associated with breast implants. Mastology 28:67–68Google Scholar